42 results found.

Bipolar 1 Disorder Clinical Trial using ELND005; Lamotrigine; Valproic acid; Placebo

Elan Pharmaceuticals - Recruiting 18 years to 65 years.
- A Prospective, Randomized, Double-Blind, Placebo-Controlled, Phase 2 Safety and Efficacy Study of Oral ELND005 as an Adjunctive Maintenance Treatment in Patients With Bipolar I Disorder.
ELND005; Lamotrigine; Valproic acid; Placebo

Schizophrenia, Schizoaffective Disorder, Bipolar Disorder, or Maj Clinical Trial using Ending Self Stigma (ESS); Health and Wellness Group

Department of Veterans Affairs - Recruiting 18 years to 80 years.
- Reducing Internalized Stigma In People With Serious Mental Illness.
Ending Self Stigma (ESS); Health and Wellness Group

Bipolar Disorder Depression Clinical Trial using Minocycline; Aspirin; placebo

Laureate Institute for Brain Research, Inc. - Recruiting 18 years to 65 years.
- Minocycline and Aspirin in the Treatment of Bipolar Depression.
Minocycline; Aspirin; placebo

Bipolar Disorder, Major Depressive Episode, or Suicidal Ideation Clinical Trial using Ketamine; Midazolam

New York State Psychiatric Institute - Recruiting 18 years to 65 years.
- Ketamine vs. Midazolam in Bipolar Depression.
Ketamine; Midazolam

Bipolar Disorder, Depression, Anxiety Disorders, Schizophrenia, T Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting N/A or older.
- Brain Procurement for the Human Brain Collection Core.

Bipolar Disorder Clinical Trial

Northwestern University - Recruiting 18 years to 55 years.
- Circadian Phase in Bipolar Depression: Is it Delayed and Does it Normalize With Remission?.

Depression, or Major Depression/Bipolar Disorder Clinical Trial using Ketamine; Riluzole; FDG

National Institutes of Health Clinical Center (CC) - Recruiting 18 years to 65 years.
- Investigation of the Rapid (Next Day) Antidepressant Effects of an NMDA Antagonist.
Ketamine; Riluzole; FDG

Bipolar 1 Disorder Clinical Trial using asenapine; placebo

Merck Sharp & Dohme Corp. - Recruiting 18 years or older.
- A Double-Blind, Placebo-Controlled Trial of Asenapine in the Prevention of Recurrence of a Mood Episode After Stabilization of an Acute Manic/Mixed Episode in Subjects With Bipolar 1 Disorder (Phase 3B, Protocol P06384).
asenapine; placebo

Schizophrenia, Schizoaffective Disorder, Bipolar Disorder With Ps Clinical Trial

University of Arizona - Recruiting 18 years to 75 years.
- Social Cognition in Longstanding Psychosis.

Schizophrenia, Schizoaffective Disorder, Bipolar Disorder With Ps Clinical Trial using Group Cognitive Behavioral Therapy; Multifamily Group Psychoeducation

University of Arizona - Recruiting 18 years to 35 years.
- Mediators and Moderators of Treatment Outcome in Recent-Onset Psychosis.
Group Cognitive Behavioral Therapy; Multifamily Group Psychoeducation

Bipolar Disorder Clinical Trial using CR + DCS (D-cycloserine); CR + placebo

University of Arizona - Recruiting 18 years to 65 years.
- A Randomized Controlled Trial of Cognitive Remediation and D-cycloserine for Individuals With Bipolar Disorder.
CR + DCS (D-cycloserine); CR + placebo

Bipolar 1 Disorder Clinical Trial using Asenapine; Placebo

Merck Sharp & Dohme Corp. - Recruiting 18 years or older.
- A Phase 3b, Multicenter, Double-Blind, Fixed-Dose, Parallel-Group, Three Week Placebo Controlled Trial Evaluating the Safety and Efficacy of Asenapine in Subjects With Bipolar 1 Disorder Experiencing an Acute Manic or Mixed Episode (Protocol P05691).
Asenapine; Placebo

Bipolar I Disorder Clinical Trial using asenapine

Merck Sharp & Dohme Corp. - Recruiting 18 years or older.
- A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045]).
asenapine

Bipolar Disorder Clinical Trial using Ramelteon; Placebo

Takeda - Recruiting 18 years to 75 years.
- A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Once a Day, TAK-375 (Ramelteon) Tablet for Sublingual Administration (TAK-375SL Tablet) as an Adjunctive Therapy in the Treatment of Acute Depressive Episodes Associated With Bipolar 1 Disorder in Adult Subjects.
Ramelteon; Placebo

Bipolar Disorder Clinical Trial using Modafinil; Placebo

Mount Sinai School of Medicine - Recruiting 18 years to 55 years.
- Targeting Circadian and Cognitive Dysfunction in Bipolar Disorder With Modafinil.
Modafinil; Placebo

Bipolar Disorder Clinical Trial using Ramelteon SL; Placebo

Takeda - Recruiting 18 years to 75 years.
- A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Once a Day, TAK-375SL as an Adjunctive Therapy to Treatment-as-Usual in the Maintenance Treatment of Bipolar I Disorder in Adult Patients.
Ramelteon SL; Placebo

Bipolar Disorder Clinical Trial using Curcumin

Sunnybrook Health Sciences Centre - Recruiting 13 years to 19 years.
- Adjunctive Curcumin for Symptomatic Adolescents With Bipolar Disorder: Brain and Body Considerations.
Curcumin

Schizophrenia, or Bipolar Disorder Clinical Trial using Lurasidone

Sunovion - Recruiting N/A or older.
- A Long-term, Multicenter, Open-Label, Flexible Dose Continuation Study in Subjects Who Have Completed a Prior Lurasidone Study.
Lurasidone

Bipolar I Disorder Clinical Trial using Lurasidone

Sunovion - Recruiting 18 years or older.
- A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder.
Lurasidone

Bipolar I Disorder Clinical Trial using Lurasidone; Placebo

Sunovion - Recruiting 18 years or older.
- A Randomized, Double-blind, Placebo-controlled, Flexible-dose, Parallel-group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Prevention of Recurrence in Subjects With Bipolar I Disorder.
Lurasidone; Placebo

Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorde Clinical Trial using Risperidone; Omega-3 capsules; Amber 50/50 Soybean/Corn Placebo

North Shore Long Island Jewish Health System - Recruiting 15 years to 40 years.
- Detecting Which Patients With Schizophrenia Will Improve With Omega-3 Treatment.
Risperidone; Omega-3 capsules; Amber 50/50 Soybean/Corn Placebo

Bipolar Disorder Clinical Trial using FK949E; Placebo

Astellas Pharma Inc - Recruiting 20 years to 64 years.
- Phase II/III Study of FK949E - Placebo-controlled, Double-blind, Parallel-group Comparative Study and Open-label, Non-controlled Extension Study in Bipolar Disorder Patients With Major Depressive Episodes -.
FK949E; Placebo

Bipolar Disorder Clinical Trial using Lithium; Valproate; Oxcarbazepine; Quetiapine; Olanzapine; Ziprasidone

Guangzhou Psychiatric Hospital - Recruiting 18 years to 65 years.
- Comparative Efficacy and Acceptability of Lithium, Valproate, Oxcarbazepine, Quetiapine, Olanzapine, and Ziprasidone in Bipolar I Disorder, Manic or Mixed Phase.
Lithium; Valproate; Oxcarbazepine; Quetiapine; Olanzapine; Ziprasidone

Schizophrenia, or Bipolar Disorder Clinical Trial using Integrated Care with Assertive community treatment with hometreatment, n=120; SC

Universit„tsklinikum Hamburg-Eppendorf - Recruiting 12 years to 29 years.
- Integrated Care in Early Psychosis (ICEP Study): a 12-month Quasi Experimental Study With Historic Control Group.
Integrated Care with Assertive community treatment with hometreatment, n=120; SC

Schizophrenia, or Bipolar Disorder Clinical Trial using CBT2go; Smartphone

University of California, San Diego - Recruiting 18 years to 55 years.
- Real-Time Mobile Cognitive Behavioral Intervention for Serious Mental Illness.
CBT2go; Smartphone

Bipolar Disorder, or Depression Clinical Trial using IPSRT plus placebo (IPSRT-PLA); IPSRT plus quetiapine

University of Pittsburgh - Recruiting 18 years to 65 years.
- Acute Psychotherapy for Bipolar II Depression.
IPSRT plus placebo (IPSRT-PLA); IPSRT plus quetiapine

Depressive Disorder, Major, Bipolar Disorder, Panic Disorder, or Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years to 65 years.
- Development of Functional and Structural Magnetic Resonance Imaging Techniques for the Study of Mood and Anxiety Disorders.

Mood Disorder, or Bipolar Disorder Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 7 years to 25 years.
- Characterization and Pathophysiology of Severe Mood and Behavioral Dysregulation in Children and Youth.

Bipolar Disorder Clinical Trial using Lamotrigine; Placebo

GlaxoSmithKline - Recruiting 18 years or older.
- A Fixed-Dose Study of Lamotrigine Versus Placebo in the Long Term Prevention of Relapse and/or Recurrence of a Manic, Hypomanic, Mixed or Depressive Episode in Adult Subjects With Bipolar I Disorder.
Lamotrigine; Placebo

Acute Depressive Episode Clinical Trial using Ramelteon SL; Placebo

Takeda - Recruiting 18 years or older.
- A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Once a Day, TAK-375 (Ramelteon) Tablet for Sublingual Administration (TAK-375SL Tablet) in the Treatment of Acute Depressive Episodes Associated With Bipolar I Disorder in Adult Patients Who Are on Lithium and/or Valproate.
Ramelteon SL; Placebo

Bipolar Disorder Clinical Trial using Lithium, valproate, lamotrigine

Emory University - Recruiting 18 years to 65 years.
- Decision-Making in Bipolar Disorder.
Lithium, valproate, lamotrigine

Major Depressive Disorder, Bipolar Disorder, or Biomarker Panel Clinical Trial using MDDScoreTM

University of Utah - Recruiting 13 years to 21 years.
- Detecting Depression and Bipolar Disorder in Adolescents Using a Biomarker Panel.
MDDScoreTM

Alcohol Use Disorders, or Bipolar Disorder Clinical Trial using Zonisamide; Placebo

VA Connecticut Healthcare System - Recruiting 18 years to 65 years.
- Zonisamide for Heavy Drinkers With Bipolar Disorder.
Zonisamide; Placebo

Bipolar Disorder, or Major Depressive Disorder Clinical Trial using Enhanced Care; Family-Focused Treatment

University of California, Los Angeles - Recruiting 9 years to 17 years.
- Early Intervention for Youth at Risk for Bipolar Disorder.
Enhanced Care; Family-Focused Treatment

Bipolar Affective Disorder Clinical Trial using Mood stabilizer treatment

University of California, San Diego - Recruiting 18 years or older.
- Pharmacogenomics of Mood Stabilizer Response in Bipolar Disorder (PGBD).
Mood stabilizer treatment

Bipolar Type II Disorder, or Depression, Bipolar Clinical Trial using Northern Light Technology (SADelite lamp) bright light-therapy; Northern Light Technology (SADelite lamp) Dim light-therapy

Douglas Mental Health University Institute - Recruiting 18 years to 70 years.
- Light-Therapy in the Treatment of the Acute Phase of the Bipolar Type II Depression: Double-Blind, Placebo-Controlled Study to Establish Efficacy and Safety.
Northern Light Technology (SADelite lamp) bright light-therapy; Northern Light Technology (SADelite lamp) Dim light-therapy

Schizophrenia, Schizoaffective Disorder, Major Depression, Bipola Clinical Trial using Eicosapentaenoic acid (omega-3 fatty acid); Placebo

University of Pittsburgh - Recruiting 18 years or older.
- CAD Risk in Schizophrenia: Effect of Omega-3 Fatty Acid Supplementation.
Eicosapentaenoic acid (omega-3 fatty acid); Placebo

Bipolar Disorder Clinical Trial using Neurocognitive Tasks; EEG; fMRI

National Institute of Mental Health (NIMH) - Recruiting 7 years to 17 years.
- Examining Neurocognitive Profiles of Bipolar Disorder and Attention-Deficit Hyperactivity Disorder.
Neurocognitive Tasks; EEG; fMRI

Bipolar Disorder Clinical Trial using Valporic Acid

Duke University - Recruiting 18 years to 80 years.
- Bipolar Disorder in Late Life.
Valporic Acid

Bipolar Affective Disorder Clinical Trial using TMS; Sham TMS

Bayside Health - Recruiting 18 years to 70 years.
- A Double-Blind Sham Controlled Trial of rTMS in the Treatment of Bipolar Depression.
TMS; Sham TMS

Bipolar Disorder Clinical Trial using ropinirole

Cambridge Health Alliance - Recruiting 18 years to 64 years.
- A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy of Ropinirole in the Treatment of Depression in Bipolar Disorder.
ropinirole

Bipolar Disorder, or Major Depressive Disorder Clinical Trial using ropinirole

Sheba Medical Center - Recruiting 18 years or older.
- A Placebo Controlled Trial of the Dopamine D-2 Receptor Agonist Ropinirole in Treatment of 60 Patients With Refractory Bipolar I and II Depression..
ropinirole